The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.
The global market for contract pharmaceutical manufacturing services should grow from $89.7 billion in 2021 to $110.8 billion by 2026, at a CAGR of 4.8% during the forecast period of 2021-2026.
The global market for contract pharmaceutical research services should grow from $67.1 billion in 2021 to $89.8 billion by 2026, at a CAGR of 6.0% during the forecast period of 2021-2026.
Report Scope
The primary objective of this report is to provide in-depth knowledge of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market.
The contract manufacturing segment is further analyzed by various dosage forms, over-the-counter (OTC) options and nutraceuticals, and drug delivery technologies.
The drug discovery and development segments of pharmaceutical research through outsourcing have been analyzed under the contract research market. The clinical research segment is further analyzed on the basis of preclinical and clinical research. Adaptive clinical trials have also been discussed.
The contract packaging market covers primary, secondary and tertiary packaging. To analyze the primary packaging market, primary containers are categorized as blisters, bottles and others (e.g., pre-fillable-syringes, inhalers, vials and ampoules, caps and closures, dosing droppers, labels, accessories).
The scope of the study is global. the publisher analyzes each market and its application, regulatory environment, new products and advancements, market projections and market shares.
The Report Includes
- 35 data tables
- An updated review of the global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging services within the industry
- Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of market size and market forecast for global pharmaceutical contract research, manufacturing, and packaging services market, and their corresponding market share analysis by type, dosage form, formulation, application, and geographic region
- Discussion of key market dynamics (DROs), technological advancements, product launches, and regulatory landscape in the context of contract manufacturing and contract pharmaceutical research services
- Impact of COVID-19 on pharmaceutical supply chain and outsourcing practices affecting the progress of this market
- Market outlook and opportunity assessment of the contract manufacturing industry structure, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
- Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
- Descriptive company profiles of the major market players, including 3M Co., AbbVie, Albany Molecular Research Inc. (AMRI), Baxter International Inc., Boehringer Ingelheim, Dr Reddy’s Laboratories Ltd., Lonza Group, Jubilant Life Sciences Ltd., Pfizer CentreOne, and Takeda Pharmaceuticals
Table of Contents
Chapter 1 Introduction
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- What's New in This Update?
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
- Key Highlights
Chapter 3 Market and Technology Background
- Outsourcing Benefits
- Outsourcing Drawbacks
- Contract Manufacturing
- Contract Manufacturing Types
- Evolution of Contract Manufacturing Organizations
- Outsourcing
- Criteria for Evaluating a Contract Manufacturer
- Core Capabilities of Contract Manufacturing Organization
- Core Functional Areas Requiring Constant Attention
- Popular Matrices Used to Choose an Outsourcing Partner for Pharmaceutical Manufacturing
- Top Sources of Dissatisfaction of Client or Contract Giver
- Challenges in Contract Manufacturing
- Services Offered by Contract Manufacturing Organizations
- Contract Research
- Selecting a Contract Research Organization
- Services Offered by Contract Research Organizations
- Checklist for Selecting a Contract Research Organization
- Benefits of Using a Contract Research Organization
- Sponsor/CRO Relationship
- Contract Packaging
- Packaging Types
- Key Considerations While Choosing a Contract Packager
- Need of a Contract Packager
- Expectations of the Pharmaceutical Industry from the Packaging Industry
- Ethical Standards for Contract Packagers
Chapter 4 Contract Research, Manufacturing and Packaging Market Dynamics
- Market Dynamics
- Market Drivers
- Market Challenges and Threats
Chapter 5 Contract Manufacturing Services: Market Landscape
- Contract Manufacturing of Bulk Drugs and Active Pharmaceutical Ingredients
- Market Overview
- Market Revenue
- Contract Manufacturing of Dosage Forms
- Market by Type
- Market by Region
- Market by Formulations
- Contract Manufacturing of Advanced Drug Delivery Products
- Market Overview
- Market by Region
- Market by Formulations
- Contract Manufacturing of Over-the-Counter and Nutritional Products
- Market Overview
- Market Revenue
- Market by Formulations
Chapter 6 Contract Research Services: Market Landscape
- Market by Discipline
- Market Overview
- Market Revenue
- Market by Region
- Market Overview
- Market Revenue
- Contract Drug Discovery Market by Region
- Contract Drug Development Market by Region
- Contract Drug Development Market by Type
Chapter 7 Contract Packaging Services: Market Landscape
- Market by Type
- Market Overview
- Market Revenue
- Primary Packaging Services Market by Type
- Market by Region
- Market Overview
- Market Revenue
- Primary Packaging Services Market by Region
- Secondary Packaging Services Market by Region
- Market for Other Types of Contract Packaging Services by Region
Chapter 8 Market Breakdown by Application
- Contract Manufacturing by Application and Therapeutics
- Cardiovascular
- Antibiotics
- Analgesics
- Oncology
- Antibody Drug Conjugates
- Antivirals
- Reproductive Drug Products
- Other Drugs
- Market Revenue
- Contract Research by Application and Therapeutic Area
- Cardiology
- Oncology
- Inflammation and Immunology
- Neuroscience
- Infectious Diseases
- Vaccines
- Others
Chapter 9 Regulatory Landscape
- Regulations for Contract Manufacturing Services
- U.S. Regulations
- European Regulation
- Regulations for Contract Pharmaceutical Clinical Research in Each Stage of Drug Discovery and Development Process
- Pre-discovery
- Drug Discovery
- Pre-clinical
- Clinical
- Phase I
- Phase II
- Phase III
- Post-marketing Surveillance and Phase IV Studies
- FDA Regulation and Impact
- The Declaration of Helsinki
- CDISC Standards
Chapter 10 Impact of COVID-19 on Pharmaceutical Supply Chain and Outsourcing Practices
- Global Pharmaceutical Supply Chain
- Global API Supply Chain
- Impact of COVID-19 on API Production and Supply Chain
- API Pricing Trends and Increases Amidst COVID-19 Pandemic
Chapter 11 Competitive Landscape
- Contract Manufacturing
- Market Leaders
- Market Share Analysis by Percentage and Revenue
- Business Models
- Strategies Employed by CMOs
- Contract Research
- Market Leaders
- Market Shares
- Contract Packaging
- Market Leaders
- Market Share
Chapter 12 Company Profiles
- 3M CO.
- Abbvie Contract Manufacturing
- Aeonova Group
- Ajinomoto Althea Inc.
- Albany Molecular Research Inc. (Curia Global)
- Alcami Corp.
- Alkermes Plc
- Amcor Ltd.
- Ampac Fine Chemicals
- Aptuit Inc.
- Aradigm Corp.
- Baxter International Inc.
- BCM/Boots Manufacturing
- Boehringer Ingelheim
- Cambrex Corp.
- Catalent Inc.
- Charles River Laboratories
- Chembridge Corp.
- Chiltern International Ltd.
- Confab Laboratories
- Corden Pharma Switzerland Llc
- Dishman Pharmaceuticals And Chemicals Ltd.
- Dpt Laboratories Ltd.
- Dr. Reddy's Laboratories
- Delpharm
- Emergent Biosolutions Inc.
- Evotec Ag
- Famar S.A.
- Fareva Group
- Hovione S.A.
- Icon Plc
- Inc Research Llc
- Jubilant Lifesciences Ltd.
- Koninklijke Dsm N.V. (Royal Dsm)
- Kp Pharmaceutical Technologies Inc.
- Laboratory Corporation Of America Holdings
- Ligand Pharmaceuticals Inc.
- Lonza Group
- Mallinckrodt Public Limited Company
- Mikart Inc.
- Nextpharma Technologies
- Nitto Avecia Pharma Services Inc.
- Norwich Pharma Services
- Patheon N.V.
- Pfizer Centreone
- Piramal Enterprises Ltd.
- Ppd
- Pra Health Sciences
- Quintilesims
- Recipharm Ab
- Schott North America Inc.
- Servier Cdmo
- Sun Pharmaceutical Industries Ltd.
- Siegfried Ag
- Takeda Pharmaceuticals
- Vetter Pharma International Gmbh
- Westrock Co.
- Wockhardt Ltd.
- Wuxi Apptec
List of Tables
Summary Table: Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, Through 2026
Table 1: Global Market for Contract Manufacturing of Bulk Drug and APIs, by Region, Through 2026
Table 2: Global Market for Contract Manufacturing of Various Dosage Forms, by Type, Through 2026
Table 3: Global Market for Contract Manufacturing of Solid Dosage Forms, by Region, Through 2026
Table 4: Global Market for Contract Manufacturing of Liquid Dosage Forms (Non-sterile), by Region, Through 2026
Table 5: Global Market for Contract Manufacturing of Liquid Dosage Forms (Sterile), by Region, Through 2026
Table 6: Global Market for Contract Manufacturing of Semi-solid Dosage Forms, by Region, Through 2026
Table 7: Global Market for Contract Manufacturing of Solid Dosage Forms, by Formulation, Through 2026
Table 8: Global Market for Contract Manufacturing of Liquid Dosage Forms (Non-sterile), by Formulation, Through 2026
Table 9: Global Market for Contract Manufacturing of Liquid Dosage Forms (Sterile), by Formulation, Through 2026
Table 10: Global Market for Contract Manufacturing of Semi-solid Dosage Forms, by Formulation, Through 2026
Table 11: Contracting Companies Offering Drug-Delivery Technologies and Systems
Table 12: Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Region, Through 2026
Table 13: Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Formulation, Through 2026
Table 14: Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Region, Through 2026
Table 15: Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Formulation, Through 2026
Table 16: Global Market for Contract Research Services, by Discipline, Through 2026
Table 17: Global Market for Contract Research Services, by Region, Through 2026
Table 18: Global Market for Contract Drug Discovery, by Region, Through 2026
Table 19: Global Market for Contract Drug Development, by Region, Through 2026
Table 20: Global Market for Contract Drug Development, by Phase, Through 2026
Table 21: Global Market for Contract Packaging Services, by Type, Through 2026
Table 22: Global Market for Primary Contract Packaging Services, by Type, Through 2026
Table 23: Global Market for Contract Packaging Services, by Region, Through 2026
Table 24: Global Market for Primary Contract Packaging Services, by Region, Through 2026
Table 25: Global Market for Secondary Contract Packaging Services, by Region, Through 2026
Table 26: Global Market for Other Types of Contract Packaging Services, by Region, Through 2026
Table 27: Global Market for Contract Manufacturing Drugs, by Application, Through 2026
Table 28: Global Market for Contract Research Services, by Therapeutic Area, Through 2026
Table 29: Likelihood of Approval, by Major Disease Area/Phase
Table 30: Clinical Phase Description
Table 31: List of Key APIs and their Price Hikes, January 2020-April 2020
Table 32: Services Provided by Leading Contract Manufacturing Organizations, 2020
Table 33: Services Provided by Leading Research Firms, 2020
Table 34: Services Provided by Leading Contract Packaging Firms, 2020
List of Figures
Summary Figure: Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, 2020-2026
Figure 1: FDA cGMP Manufacturing Guidance Documents
Figure 2: FDA Site Inspections
Figure 3: European cGMP Guideline Documentation
Figure 4: European Site Inspection Outcomes
Figure 5: End-to-End Pharmaceutical Supply Chain
Figure 6: API Supply Chain
Figure 7: Global API Supply Chain Network
Figure 8: Share of Survey Results for Levels of Confidence in the Pharma Supply Chain Due to Impact of COVID-19, 2020
Figure 9: Impact of COVID-19 on Pharma Supply Chain
Figure 10: Supply Chain Disruption in the Pharmaceutical Value Chain
Figure 11: Key Antibiotic API Price Hikes, January 2020 and April 2020
Figure 12: Price Hikes of Key Antimalarial and Antiviral APIs, January 2020 and April 2020
Figure 13: Price Hikes of Key Pain and Anti-inflammatory APIs, January 2020 and April 2020
Figure 14: Price Hikes of Key Vitamin APIs, January 2020 and April 2020
Figure 15: Global Market Shares of Contract Manufacturing Services, by Top 22 Companies, 2020
Figure 16: CMO Business Models
Figure 17: Global Market Shares of Contract Research Services, by Top Companies, 2020
Figure 18: Global Market Shares of Contract Packaging Services, by Top Companies, 2020
Samples
LOADING...
Executive Summary
The nascent pharmaceutical industry of the early 20th century was comprised of companies handling drug manufacturing, marketing and distribution under one roof. The advent of the “wonder drug” penicillin during World War II changed human and animal life expectancy and also paved the way for the mass production of pharmaceuticals. The development of new instruments and assay techniques after World War II found rapid application in the realm of medicine, as research into general physiology and therapeutics prospered. After the 1950s, technological advances coupled with the understanding of molecular science opened the door for innovation in the pharmaceutical industry. The 21st century brought patent-protected, innovative and targeted biopharmaceuticals into the market. This also presented tough economic realities to small-molecule manufacturers in the form of expiring patents, growing threats to intellectual property, stringent regulations, shrinking pipelines, constricting profit margins and fierce competition. To deal with these issues, pharmaceutical companies started forming collaborations with contract manufacturing organizations (CROs). They also pursued mergers and acquisitions, as well as joint venture strategies, to get access to other markets.
The pharmaceutical industry, a highly innovation-driven industry, is knowledge-intense, highly globalized and diversified. It brings massive benefits to public health and to the economy by bringing out inventive therapies. Pharmaceutical companies squeezed by healthcare providers and governments on pricing and patent cliff approached contract manufacturing organizations to maintain their positions in this highly competitive environment. The peak of the patent cliff has passed, and research and development productivity is increasing in the industry. Outsourcing that has been transformed from “pay for services” to “partnerships and collaborations” is considered the most successful strategy to bring innovation into the drug industry. Strategic partnerships are now prevalent during all aspects of the research and development (R&D) cycle. In contrast to the traditional outsourcing model, this strategic partnership model shares the risks and rewards of innovation.
Companies Mentioned
- 3M CO.
- Abbvie Contract Manufacturing
- Aeonova Group
- Ajinomoto Althea Inc.
- Albany Molecular Research Inc. (Curia Global)
- Alcami Corp.
- Alkermes Plc
- Amcor Ltd.
- Ampac Fine Chemicals
- Aptuit Inc.
- Aradigm Corp.
- Baxter International Inc.
- BCM/Boots Manufacturing
- Boehringer Ingelheim
- Cambrex Corp.
- Catalent Inc.
- Charles River Laboratories
- Chembridge Corp.
- Chiltern International Ltd.
- Confab Laboratories
- Corden Pharma Switzerland Llc
- Delpharm
- Dishman Pharmaceuticals And Chemicals Ltd.
- DPT Laboratories Ltd.
- Dr. Reddy's Laboratories
- Emergent Biosolutions Inc.
- Evotec Ag
- Famar S.A.
- Fareva Group
- Hovione S.A.
- Icon Plc
- Inc Research Llc
- Jubilant Lifesciences Ltd.
- Koninklijke Dsm N.V. (Royal Dsm)
- Kp Pharmaceutical Technologies Inc.
- Laboratory Corporation Of America Holdings
- Ligand Pharmaceuticals Inc.
- Lonza Group
- Mallinckrodt Public Limited Company
- Mikart Inc.
- Nextpharma Technologies
- Nitto Avecia Pharma Services Inc.
- Norwich Pharma Services
- Patheon N.V.
- Pfizer Centreone
- Piramal Enterprises Ltd.
- PPD
- Pra Health Sciences
- Quintilesims
- Recipharm Ab
- Schott North America Inc.
- Servier Cdmo
- Siegfried Ag
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceuticals
- Vetter Pharma International Gmbh
- Westrock Co.
- Wockhardt Ltd.
- Wuxi Apptec
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | August 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 168 Billion |
| Forecasted Market Value ( USD | $ 214.7 Billion |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 59 |
